Trieu Vuong — SEC Form 4 filings
SEC reporting owner CIK 1587074. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-08-27 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 14 legs across 7 filings — 2,174,839 shares, $66,164 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 239,759 shares @ $0.04 ($10,693) in Oncotelic Therapeutics, Inc., filed 2026-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oncotelic Therapeutics, Inc. (OTLC) | CHAIRMAN AND CEO, Director, 10% owner | 10 | 14 legs · 2,174,839 sh · $66,164 | — | 3 |
Form 4 filings — Trieu Vuong
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-14 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Purchase (P): 240,000 @ $0.04 | EDGAR |
| 2026-06-24 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Purchase (P): 115,000 @ $0.04 · Purchase (P): 75,000 @ $0.04 · Purchase (P): 65,000 @ $0.04 | EDGAR |
| 2026-06-17 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Purchase (P): 239,759 @ $0.04 · Purchase (P): 96,000 @ $0.04 | EDGAR |
| 2026-01-26 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Grant/award (A): 4,426 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Grant/award (A): 4,065 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Purchase (P): 104,000 @ $0.01 · Purchase (P): 1 @ $0.01 · Purchase (P): 94,736 @ $0.01 | EDGAR |
| 2025-01-31 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Purchase (P): 183,066 @ $0.03 · Purchase (P): 100,003 @ $0.03 · Purchase (P): 63,775 @ $0.03 | EDGAR |
| 2024-11-26 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Purchase (P): 298,499 @ $0.03 | EDGAR |
| 2024-08-27 | 4 | Oncotelic Therapeutics, Inc. (OTLC) | Purchase (P): 500,000 @ $0.02 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1587074 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →